Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease

The recruitment status of this study is unknown because the information has not been verified recently.

Verified May 2010 by Johns Hopkins University.
Recruitment status was Recruiting

Study NCT00806676 Information provided by Johns Hopkins University

First Received on December 9, 2008. Last Updated on May 25, 2010 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Additional drug interventions recognized in this trial

Antibodies

More general drug interventions related to this trial

Sponsors listed in this trial

Johns Hopkins University
Merck